Alpha Profiles · Company Profile
PFIZER INC
Pfizer Inc. is a global biopharmaceutical leader engaged in the research, development, production, marketing, and distribution of a wide array of medicinal and vaccine products worldwide.
https://registry.alpha.ac/companies/pfizer-inc
- Entity
- Public listing published
- Primary listing
- NYSE: PFE
- Verification
- Partially verified
- Last reviewed
- 2026-09-07T22:12:30.263+00:00
Overview
Pfizer Inc. is a global biopharmaceutical leader engaged in the research, development, production, marketing, and distribution of a wide array of medicinal and vaccine products worldwide. Its comprehensive portfolio addresses diverse therapeutic areas, including cardiovascular health and women's health, featuring key brands such as the Premarin family and Eliquis. The company also offers advanced biologics, small molecule drugs, immunotherapies, and biosimilars for various conditions, exemplifie
Canonical AEGIS identity graph
Executive leadership
Current, confirmed roles are shown only when both the person Profile and supporting source record satisfy the public projection boundary. A missing role is not evidence that it does not exist.
Executive team
13 public recordsChief U.S. Commercial Officer, Executive Vice President
- State
- confirmed
- Effective
- Date not stated
- Confidence
- 94%
- Evidence
- PFE executive roster sourceMay 3, 2026
Chairman of the Board and Chief Executive Officer
- State
- confirmed
- Effective
- Date not stated
- Confidence
- 94%
- Evidence
- PFE executive roster sourceMay 3, 2026
Chairman of the Board and Chief Executive Officer
- State
- confirmed
- Effective
- Date not stated
- Confidence
- 94%
- Evidence
- PFE executive roster sourceMay 3, 2026
Chief International Commercial Officer, Executive Vice President
- State
- confirmed
- Effective
- Date not stated
- Confidence
- 94%
- Evidence
- PFE executive roster sourceMay 3, 2026
Chief Strategy and Innovation Officer and Executive Vice President
- State
- confirmed
- Effective
- Date not stated
- Confidence
- 94%
- Evidence
- PFE executive roster sourceMay 3, 2026
Chief Strategy and Innovation Officer and Executive Vice President
- State
- confirmed
- Effective
- Date not stated
- Confidence
- 94%
- Evidence
- PFE executive roster sourceMay 3, 2026
Chief Scientific Officer and President, Research Development
- State
- confirmed
- Effective
- Date not stated
- Confidence
- 94%
- Evidence
- PFE executive roster sourceMay 3, 2026
Chief Scientific Officer and President, Research Development
- State
- confirmed
- Effective
- Date not stated
- Confidence
- 94%
- Evidence
- PFE executive roster sourceMay 3, 2026
Chief Financial Officer, Executive Vice President
- State
- confirmed
- Effective
- Date not stated
- Confidence
- 94%
- Evidence
- PFE executive roster sourceMay 3, 2026
Chief Legal Officer, Executive Vice President
- State
- confirmed
- Effective
- Date not stated
- Confidence
- 94%
- Evidence
- PFE executive roster sourceMay 3, 2026
Chief Digital and Technology Officer, Executive Vice President
- State
- confirmed
- Effective
- Date not stated
- Confidence
- 94%
- Evidence
- PFE executive roster sourceMay 3, 2026
Chief Global Supply and Quality Officer, Executive Vice President
- State
- confirmed
- Effective
- Date not stated
- Confidence
- 94%
- Evidence
- PFE executive roster sourceMay 3, 2026
Chief People Experience Officer, Executive Vice President
- State
- confirmed
- Effective
- Date not stated
- Confidence
- 94%
- Evidence
- PFE executive roster sourceMay 3, 2026
Governance leadership
Boards & Committees
Board and committee assignments appear only when the canonical public projection retains a current role and supporting source. Unpublished records are not interpreted as absence.
Record as of Sep 7, 2026. Chair, executive office, Lead Independent Director and committee appointments retain their separate source roles. A complete board composition denominator and committee charters are not established by a partial roster.
Board roles
12 public records- State
- confirmed
- Effective
- From Jan 1, 2018
- Confidence
- 95%
- Evidence
- Pfizer director board sourceMar 12, 2026
- State
- confirmed
- Effective
- From Jan 1, 2024
- Confidence
- 95%
- Evidence
- Pfizer director board sourceJan 1, 2024
- State
- unconfirmed
- Effective
- From Jan 1, 2018
- Confidence
- 85%
- Evidence
- PFIZER INC DEF 14A 2026-03-12Mar 12, 2026
- State
- confirmed
- Effective
- From Jan 1, 2014
- Confidence
- 95%
- Evidence
- Pfizer director board sourceJan 1, 2014
- State
- unconfirmed
- Effective
- From Jan 1, 2020
- Confidence
- 85%
- Evidence
- PFIZER INC DEF 14A 2026-03-12Mar 12, 2026
- State
- unconfirmed
- Effective
- From Jan 1, 2015
- Confidence
- 85%
- Evidence
- PFIZER INC DEF 14A 2026-03-12Mar 12, 2026
- State
- confirmed
- Effective
- From Jan 1, 2024
- Confidence
- 95%
- Evidence
- Pfizer director board sourceJan 1, 2024
- State
- confirmed
- Effective
- From Jan 1, 2017
- Confidence
- 95%
- Evidence
- Pfizer director board sourceJan 1, 2017
- State
- unconfirmed
- Effective
- Date not stated
- Confidence
- 85%
- Evidence
- PFIZER INC DEF 14A 2026-03-12Mar 12, 2026
- State
- confirmed
- Effective
- From Jan 1, 2013
- Confidence
- 95%
- Evidence
- Pfizer director board sourceMar 12, 2026
- State
- unconfirmed
- Effective
- From Jan 1, 2020
- Confidence
- 85%
- Evidence
- PFIZER INC DEF 14A 2026-03-12Mar 12, 2026
- State
- unconfirmed
- Effective
- From Jan 1, 2007
- Confidence
- 85%
- Evidence
- PFIZER INC DEF 14A 2026-03-12Mar 12, 2026
Source record
Alpha canonical company public projection
Supports Company identity, Published leadership, Entity status boundary
Reviewed 2026-09-07T22:12:30.263+00:00
PFIZER INC Form 10-K (filed 2026-02-26)
Supports Official website
Reviewed 2026-08-29T22:19:43Z